Literature DB >> 29465126

Effects of a galacto-oligosaccharide-rich diet on fecal microbiota and metabolite profiles in mice.

W Cheng1, J Lu2, W Lin2, X Wei2, H Li2, X Zhao2, A Jiang1, J Yuan2.   

Abstract

Galacto-oligosaccharides (GOS) are prebiotics that positively affect the host's gut microbiota, which is important for the health of the host. Most previous studies focused on specific flora components (e.g. Bifidobacterium and Lactobacillus); very few have investigated the relationship between flora and metabolites. Here, we used 16S rRNA analysis and metabolomics to analyze the effect of GOS on microbiota and metabolites. Results show that the abundance of Ruminococcaceae and Oscillibacter decreased significantly in GOS-fed mice. Twenty-one metabolites, including oleic acid, arachidic acid, and behenic acid, decreased significantly in the GOS-fed mice. Fatty acid synthesis and blood triglyceride content significantly decreased in the GOS-fed mice compared with those in the control mice, suggesting that GOS may improve lipid metabolism in mice. Additionally, after three weeks of a GOS-rich diet, the mouse microbiota was significantly enriched in Alloprevotella, Bacteroides, and Parasutterella. The blood glucose level of the GOS-fed group was significantly higher than that of the control group, whereas the abundance of Coprococcus and Odoribacter (butyrate-producing bacteria) was significantly decreased. The metabolism of butyrate, known to reduce plasma glucose levels, was significantly downregulated in the GOS-fed mice, an effect potentially detrimental to the glucose metabolism of the host. This dual-omics analysis provided important information on the changes in host-microbe-metabolite interactions resulting from GOS supplementation. Our results provide evidence that GOS may improve lipid metabolism, and that long-term GOS supplementation had a detrimental effect on the host's glucose metabolism, which could be important for optimizing methods of prebiotic supplementation and developing approaches to prevent diseases using prebiotic interventions.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29465126     DOI: 10.1039/c7fo01720k

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  20 in total

Review 1.  Gut microbiota: a new path to treat obesity.

Authors:  Giovanna Muscogiuri; Elena Cantone; Sara Cassarano; Dario Tuccinardi; Luigi Barrea; Silvia Savastano; Annamaria Colao
Journal:  Int J Obes Suppl       Date:  2019-04-12

Review 2.  Update on the Gastrointestinal Microbiome in Systemic Sclerosis.

Authors:  Chiara Bellocchi; Elizabeth R Volkmann
Journal:  Curr Rheumatol Rep       Date:  2018-06-25       Impact factor: 4.592

3.  Maternal Exercise Improves High-Fat Diet-Induced Metabolic Abnormalities and Gut Microbiota Profiles in Mouse Dams and Offspring.

Authors:  Liyuan Zhou; Xinhua Xiao; Ming Li; Qian Zhang; Miao Yu; Jia Zheng; Mingqun Deng
Journal:  Front Cell Infect Microbiol       Date:  2020-06-17       Impact factor: 5.293

4.  Maternal Genistein Intake Mitigates the Deleterious Effects of High-Fat Diet on Glucose and Lipid Metabolism and Modulates Gut Microbiota in Adult Life of Male Mice.

Authors:  Liyuan Zhou; Xinhua Xiao; Qian Zhang; Jia Zheng; Mingqun Deng
Journal:  Front Physiol       Date:  2019-07-30       Impact factor: 4.566

5.  Dietary Methionine Supplementation Exacerbates Gastrointestinal Toxicity in a Mouse Model of Abdominal Irradiation.

Authors:  Laura E Ewing; Charles M Skinner; Rupak Pathak; Eric U Yee; Kim Krager; Patrick C Gurley; Stepan Melnyk; Marjan Boerma; Martin Hauer-Jensen; Igor Koturbash
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-09-28       Impact factor: 7.038

Review 6.  Mechanisms of Action of Prebiotics and Their Effects on Gastro-Intestinal Disorders in Adults.

Authors:  Michele Pier Luca Guarino; Annamaria Altomare; Sara Emerenziani; Claudia Di Rosa; Mentore Ribolsi; Paola Balestrieri; Paola Iovino; Giulia Rocchi; Michele Cicala
Journal:  Nutrients       Date:  2020-04-09       Impact factor: 5.717

7.  Cloning and Characterization of a New β-Galactosidase from Alteromonas sp. QD01 and Its Potential in Synthesis of Galacto-Oligosaccharides.

Authors:  Dandan Li; Shangyong Li; Yanhong Wu; Mengfei Jin; Yu Zhou; Yanan Wang; Xuehong Chen; Yantao Han
Journal:  Mar Drugs       Date:  2020-06-14       Impact factor: 5.118

8.  Short Administration of Combined Prebiotics Improved Microbial Colonization, Gut Barrier, and Growth Performance of Neonatal Piglets.

Authors:  Yujun Wu; Xiangyu Zhang; Dandan Han; Hao Ye; Shiyu Tao; Yu Pi; Junying Zhao; Lijun Chen; Junjun Wang
Journal:  ACS Omega       Date:  2020-08-04

9.  Seabuckthorn (Hippophaë rhamnoides) Freeze-Dried Powder Protects against High-Fat Diet-Induced Obesity, Lipid Metabolism Disorders by Modulating the Gut Microbiota of Mice.

Authors:  Caixia Guo; Li Han; Meiping Li; Ligang Yu
Journal:  Nutrients       Date:  2020-01-20       Impact factor: 5.717

Review 10.  Microphysiological Engineering of Immune Responses in Intestinal Inflammation.

Authors:  Yoko M Ambrosini; Woojung Shin; Soyoun Min; Hyun Jung Kim
Journal:  Immune Netw       Date:  2020-04-08       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.